Differential Regulation of SOX9 Protein During Chondrogenesis of Induced Pluripotent Stem Cells Versus Mesenchymal Stromal Cells: A Shortcoming for Cartilage Formation.

Induced pluripotent stem cells (iPSCs) are an attractive cell source for cartilage regeneration, but current in vitro chondrogenic differentiation protocols yield insufficient results. In search for shortcomings of iPSC chondrogenesis, this study investigated whether SOX9 protein was adequately regulated during multiphase chondrogenic differentiation of two human iPSC lines in a comparable manner like during mesenchymal stromal cell (MSC) chondrogenesis. Upon generation of intermediate mesenchymal progenitor cells (iMPCs), SOX9 was induced and reached variable protein levels compared to MSCs. Along with an altered condensation behavior, iMPC cartilage formation was less robust compared to MSCs and better in the iMPC line with higher SOX9 protein levels. Despite efficient Smad-2/3 phosphorylation, TGF-β-driven chondrogenic stimulation downregulated SOX9 protein in iMPCs rather than increasing levels like in MSCs. Chondrogenesis was further improved by cotreatment with TGF-β + BMP-4, which appeared to shorten the duration of the SOX9 protein decline. However, this was insufficient to overcome heterogenic outcome and came at the expense of undesired hypertrophy. In iMPCs, but not MSCs, high levels of the SOX9-antagonizing hsa-miR-145 correlated with low SOX9 protein quantity. Thus, considerable iMPC heterogeneity with variable SOX9 protein levels, an altered condensation pattern, and low early SOX9 inducibility appeared as critical shortcomings of iPSC chondrogenesis. We suggest consistent quality of intermediate cell populations with high SOX9 protein induction as important indicators to obtain robust cartilage formation from iPSCs. The impact of this study is the identification of a SOX9 protein regulation opposite to MSC chondrogenesis that will now enable a selective adaptation of the currently limited protocols to the specific needs of iPSCs.

[1]  R. O’Keefe,et al.  Notch signaling controls chondrocyte hypertrophy via indirect regulation of Sox9 , 2015, Bone Research.

[2]  J. Utikal,et al.  NF1 loss induces senescence during human melanocyte differentiation in an iPSC‐based model , 2015, Pigment cell & melanoma research.

[3]  Sakae Tanaka,et al.  Hyaline cartilage formation and tumorigenesis of implanted tissues derived from human induced pluripotent stem cells. , 2015, Biomedical research.

[4]  S. Matsuda,et al.  Generation of Scaffoldless Hyaline Cartilaginous Tissue from Human iPSCs , 2015, Stem cell reports.

[5]  Fan Yang,et al.  Improved Approach for Chondrogenic Differentiation of Human Induced Pluripotent Stem Cells , 2015, Stem Cell Reviews and Reports.

[6]  O. Ohara,et al.  Enhanced Chondrogenesis of Induced Pluripotent Stem Cells From Patients With Neonatal‐Onset Multisystem Inflammatory Disease Occurs via the Caspase 1–Independent cAMP/Protein Kinase A/CREB Pathway , 2015, Arthritis & rheumatology.

[7]  M. Ghert,et al.  The Epigenetic Regulation of SOX9 by miR‐145 in Human Chondrosarcoma , 2015, Journal of cellular biochemistry.

[8]  V. Lefebvre,et al.  SOXC proteins amplify canonical WNT signaling to secure nonchondrocytic fates in skeletogenesis , 2014, The Journal of cell biology.

[9]  A. Cheng,et al.  Cartilage Repair Using Human Embryonic Stem Cell‐Derived Chondroprogenitors , 2014, Stem cells translational medicine.

[10]  Wolfgang Wagner,et al.  Epigenetic Rejuvenation of Mesenchymal Stromal Cells Derived from Induced Pluripotent Stem Cells , 2014, Stem cell reports.

[11]  Stan Gronthos,et al.  Generation of functional mesenchymal stem cells from different induced pluripotent stem cell lines. , 2014, Stem cells and development.

[12]  R. Tuan,et al.  Functional comparison of human-induced pluripotent stem cell-derived mesenchymal cells and bone marrow-derived mesenchymal stromal cells from the same donor. , 2014, Stem cells and development.

[13]  SaittaBiagio,et al.  Patient-Derived Skeletal Dysplasia Induced Pluripotent Stem Cells Display Abnormal Chondrogenic Marker Expression and Regulation by BMP2 and TGFβ1 , 2014 .

[14]  T. Mikkelsen,et al.  microRNA-140 targets RALA and regulates chondrogenic differentiation of human mesenchymal stem cells by translational enhancement of SOX9 and ACAN. , 2014, Stem cells and development.

[15]  E. Schwarz,et al.  TAK1 regulates SOX9 expression in chondrocytes and is essential for postnatal development of the growth plate and articular cartilages , 2013, Journal of Cell Science.

[16]  K. Lyons,et al.  Human Developmental Chondrogenesis as a Basis for Engineering Chondrocytes from Pluripotent Stem Cells , 2013, Stem cell reports.

[17]  A. Shiras,et al.  MiR-145 functions as a tumor-suppressive RNA by targeting Sox9 and adducin 3 in human glioma cells. , 2013, Neuro-oncology.

[18]  K. Puttonen,et al.  Chondrogenic differentiation of human pluripotent stem cells in chondrocyte co-culture. , 2013, The international journal of biochemistry & cell biology.

[19]  Guang-Yuh Chiou,et al.  miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer. , 2013, Cancer research.

[20]  P. Cahan,et al.  Origins and implications of pluripotent stem cell variability and heterogeneity , 2013, Nature Reviews Molecular Cell Biology.

[21]  H. Drissi,et al.  Efficient differentiation of human iPSC‐derived mesenchymal stem cells to chondroprogenitor cells , 2013, Journal of cellular biochemistry.

[22]  Y. Matsumoto,et al.  Genetically Matched Human iPS Cells Reveal that Propensity for Cartilage and Bone Differentiation Differs with Clones, not Cell Type of Origin , 2013, PloS one.

[23]  P. Wright,et al.  Compound screening platform using human induced pluripotent stem cells to identify small molecules that promote chondrogenesis , 2012, Protein & Cell.

[24]  W. Richter,et al.  Proliferation as a requirement for in vitro chondrogenesis of human mesenchymal stem cells. , 2012, Stem cells and development.

[25]  E. Stanley,et al.  Human chondrogenic paraxial mesoderm, directed specification and prospective isolation from pluripotent stem cells , 2012, Scientific Reports.

[26]  J. Lahann,et al.  Derivation of Mesenchymal Stem Cells from Human Induced Pluripotent Stem Cells Cultured on Synthetic Substrates , 2012, Stem cells.

[27]  C. L. Murphy,et al.  Regulation of Human Chondrocyte Function through Direct Inhibition of Cartilage Master Regulator SOX9 by MicroRNA-145 (miRNA-145)* , 2011, The Journal of Biological Chemistry.

[28]  Andrew M. Handorf,et al.  Fibroblast Growth Factor-2 Primes Human Mesenchymal Stem Cells for Enhanced Chondrogenesis , 2011, PloS one.

[29]  D. Ying,et al.  MicroRNA-145 Regulates Chondrogenic Differentiation of Mesenchymal Stem Cells by Targeting Sox9 , 2011, PloS one.

[30]  G. Sukhikh,et al.  Human induced pluripotent stem cells derived from fetal neural stem cells successfully undergo directed differentiation into cartilage. , 2011, Stem cells and development.

[31]  H. Cheung,et al.  Activation of the extracellular signal-regulated kinases 1 and 2 (ERK1/2) is needed for the TGFβ-induced chondrogenic and osteogenic differentiation of mesenchymal stem cells. , 2011, Biochemical and biophysical research communications.

[32]  Martin J. Aryee,et al.  Epigenetic memory in induced pluripotent stem cells , 2010, Nature.

[33]  C. Hamanishi,et al.  Induction of mesenchymal progenitor cells with chondrogenic property from mouse-induced pluripotent stem cells. , 2010, Cellular reprogramming.

[34]  W. Richter,et al.  Impact of growth factors and PTHrP on early and late chondrogenic differentiation of human mesenchymal stem cells , 2010, Journal of cellular physiology.

[35]  Zhen Li,et al.  Improving chondrogenesis: potential and limitations of SOX9 gene transfer and mechanical stimulation for cartilage tissue engineering. , 2010, Tissue engineering. Part A.

[36]  Christian Heisel,et al.  Chondrogenesis of human mesenchymal stem cells by local transforming growth factor-beta delivery in a biphasic resorbable carrier. , 2010, Tissue engineering. Part A.

[37]  Ciro Indolfi,et al.  The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease , 2009, Cell Death and Differentiation.

[38]  John McAnally,et al.  MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. , 2009, Genes & development.

[39]  C. Martínez-Cué,et al.  Transforming Growth Factors β Coordinate Cartilage and Tendon Differentiation in the Developing Limb Mesenchyme* , 2009, The Journal of Biological Chemistry.

[40]  Deepak Srivastava,et al.  miR-145 and miR-143 Regulate Smooth Muscle Cell Fate Decisions , 2009, Nature.

[41]  P. Eriksson,et al.  Human embryonic stem cell-derived mesenchymal progenitors--potential in regenerative medicine. , 2009, Stem cell research.

[42]  Wen-Ling Liao,et al.  MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma , 2009, British Journal of Cancer.

[43]  V. Lefebvre,et al.  L-Sox5 and Sox6 Drive Expression of the Aggrecan Gene in Cartilage by Securing Binding of Sox9 to a Far-Upstream Enhancer , 2008, Molecular and Cellular Biology.

[44]  R. Yeh,et al.  MicroRNA regulation of cell lineages in mouse and human embryonic stem cells. , 2008, Cell stem cell.

[45]  G. Keller,et al.  Wnt, activin, and BMP signaling regulate distinct stages in the developmental pathway from embryonic stem cells to blood. , 2008, Cell stem cell.

[46]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[47]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[48]  Philip A Beachy,et al.  Misexpression of Sox9 in mouse limb bud mesenchyme induces polydactyly and rescues hypodactyly mice. , 2007, Matrix biology : journal of the International Society for Matrix Biology.

[49]  M. Genzer,et al.  A Col9a1 enhancer element activated by two interdependent SOX9 dimers , 2007, Nucleic acids research.

[50]  T. Hardingham,et al.  Regulation of SOX9 mRNA in Human Articular Chondrocytes Involving p38 MAPK Activation and mRNA Stabilization* , 2006, Journal of Biological Chemistry.

[51]  Y. Kawakami,et al.  The role of TGFβs and Sox9 during limb chondrogenesis , 2006 .

[52]  J. Elisseeff,et al.  Reorganization of actin filaments enhances chondrogenic differentiation of cells derived from murine embryonic stem cells. , 2006, Biochemical and biophysical research communications.

[53]  Y. Toyama,et al.  Involvement of Notch signaling in initiation of prechondrogenic condensation and nodule formation in limb bud micromass cultures , 2006, Journal of Bone and Mineral Metabolism.

[54]  F. Beier,et al.  RhoA/ROCK Signaling Regulates Chondrogenesis in a Context-dependent Manner* , 2006, Journal of Biological Chemistry.

[55]  D. Kimelman.  Mesoderm induction: from caps to chips , 2006, Nature Reviews Genetics.

[56]  F. Beier,et al.  RhoA/ROCK Signaling Regulates Sox9 Expression and Actin Organization during Chondrogenesis* , 2005, Journal of Biological Chemistry.

[57]  P. McCrea,et al.  Interactions between Sox9 and β-catenin control chondrocyte differentiation , 2004 .

[58]  Hans Hauner,et al.  Cartilage-like gene expression in differentiated human stem cell spheroids: a comparison of bone marrow-derived and adipose tissue-derived stromal cells. , 2003, Arthritis and rheumatism.

[59]  S. Jimenez,et al.  Regulation of Human COL9A1 Gene Expression , 2003, The Journal of Biological Chemistry.

[60]  Marie-Christine Chaboissier,et al.  The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. , 2002, Genes & development.

[61]  Noriyuki Tsumaki,et al.  Identification of an Enhancer Sequence within the First Intron Required for Cartilage-specific Transcription of the α2(XI) Collagen Gene* , 2000, The Journal of Biological Chemistry.

[62]  M Noda,et al.  SOX9 Enhances Aggrecan Gene Promoter/Enhancer Activity and Is Up-regulated by Retinoic Acid in a Cartilage-derived Cell Line, TC6* , 2000, The Journal of Biological Chemistry.

[63]  Richard R. Behringer,et al.  Sox9 is required for cartilage formation , 1999, Nature Genetics.

[64]  Véronique Lefebvre,et al.  A new long form of Sox5 (L‐Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene , 1998, The EMBO journal.

[65]  V. Lefebvre,et al.  Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesis , 1997, Developmental dynamics : an official publication of the American Association of Anatomists.

[66]  Patrick P.L. Tam,et al.  SOX9 directly regulates the type-ll collagen gene , 1997, Nature Genetics.

[67]  P N Goodfellow,et al.  SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene , 1997, Molecular and cellular biology.

[68]  N. Tommerup,et al.  Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9 , 1994, Cell.

[69]  Sahar Mansour,et al.  Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene , 1994, Nature.

[70]  L Wolpert,et al.  Cell sorting and chondrogenic aggregate formation in micromass culture. , 1987, Developmental biology.

[71]  R. Reiter,et al.  Determination of limb bud chondrocytes during a transient block of the cell cycle. , 1975, Cell differentiation.

[72]  R. Flickinger.  Muscle and cartilage differentiation in small and large explants from the chick embryo limb bud. , 1974, Developmental biology.

[73]  D. Taura,et al.  Human induced pluripotent stem cells differentiated into chondrogenic lineage via generation of mesenchymal progenitor cells. , 2013, Stem cells and development.

[74]  D. D’Lima,et al.  Rho kinase-dependent activation of SOX9 in chondrocytes. , 2010, Arthritis and rheumatism.